Experience

Akeso Announces HK$3.97 Billion Placement of Shares

August 28, 2025

Cooley advised Akeso (Hong Kong Stock Exchange: 9926.HK), a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing and commercializing innovative medicines that address global medical needs, on its HK$3.97 billion (US$509.01 million) placement of shares.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiying Wang
Counsel, Shanghai
Ying Liu
Associate, Hong Kong
April Wang
Associate, Hong Kong

Related Practices & Industries

MetaLight Inc. Announces HK$242.35 Million IPO

June 9, 2025

Cooley advised MetaLight Inc., a China-domiciled company specializing in big data analytics, on its HK$242.35 million initial public offering (IPO).

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Will Cai
Partner, Hong Kong
Lisa Yuan
Special Counsel, Beijing
Dichun Duan
Associate, Beijing
Ying Liu
Associate, Hong Kong
April Wang
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

Zenergy Announces HK$1 Billion IPO

April 14, 2025

Cooley advised the sponsors and underwriters of Jiangsu Zenergy Battery Technologies Group (Zenergy) – a lithium-ion battery manufacturer focusing on the research and development, production and sales of electric vehicle battery products, electrochemical energy storage battery products and aviation battery products – in connection with Zenergy’s HK$1 billion global initial public offering.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Will Cai
Partner, Hong Kong
Kaiting Yang
Counsel, Hong Kong
Yiying Wang
Counsel, Shanghai
Dichun Duan
Associate, Beijing
April Wang
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai

Related Practices & Industries

BrainAurora Medical Technology – HK$583 Million IPO

January 8, 2025

Cooley advised the sponsors and underwriters of BrainAurora Medical Technology, a provider of medical diagnostics and digital therapies, in connection with the company’s HK$583 million initial public offering.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Kaiting Yang
Counsel, Hong Kong
Yiying Wang
Counsel, Shanghai
April Wang
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

Akeso Completes HK$1.9 Billion Follow-On Public Offering

October 22, 2024

Cooley advised Akeso (Hong Kong Stock Exchange code: 9926.HK), a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing and commercializing innovative medicines that address global medical needs, on its HK$1.9 billion (approximately US$250 million) follow-on public offering.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Ying Liu
Associate, Hong Kong
April Wang
Associate, Hong Kong

Related Practices & Industries

Admissions and credentials

Solicitor of Hong Kong

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.